GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ObsEva SA (CHIX:OBSNz) » Definitions » YoY Rev. per Sh. Growth

ObsEva (CHIX:OBSNZ) YoY Rev. per Sh. Growth : -33.59% (As of Dec. 2022)


View and export this data going back to 2018. Start your Free Trial

What is ObsEva YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. ObsEva's YoY Rev. per Sh. Growth for the quarter that ended in Dec. 2022 was -33.59%.

ObsEva's Revenue per Share for the three months ended in Dec. 2022 was CHF0.17.


ObsEva YoY Rev. per Sh. Growth Historical Data

The historical data trend for ObsEva's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ObsEva YoY Rev. per Sh. Growth Chart

ObsEva Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
YoY Rev. per Sh. Growth
Get a 7-Day Free Trial Premium Member Only - - - - -26.84

ObsEva Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22
YoY Rev. per Sh. Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -33.59

ObsEva YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

ObsEva's YoY Rev. per Sh. Growth for the fiscal year that ended in Dec. 2022 is calculated as:

YoY Rev. per Sh. Growth (A: Dec. 2022 )
=(Revenue per Share (A: Dec. 2022 )-Revenue per Share (A: Dec. 2021 ))/ | Revenue per Share (A: Dec. 2021 ) |
=(0.199-0.272)/ | 0.272 |
=-26.84 %

ObsEva's YoY Rev. per Sh. Growth for the quarter that ended in Dec. 2022 is calculated as:

YoY Rev. per Sh. Growth (Q: Dec. 2022 )
=(Revenue per Share (Q: Dec. 2022 )-Revenue per Share (Q: Dec. 2021 )) / | Revenue per Share (Q: Dec. 2021 )) |
=(0.17-0.256)/ | 0.256 |
=-33.59 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ObsEva YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of ObsEva's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


ObsEva (CHIX:OBSNZ) Business Description

Traded in Other Exchanges
N/A
Address
Chemin des Aulx, 12, Plan-les-Ouates, Geneva, CHE, 1228
ObsEva SA is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a woman's reproductive health and pregnancy. The Company operates in one segment, which is the research and development of innovative women's reproductive, health, and pregnancy therapeutics. It includes advancing a development program for Nolasiban, an oral oxytocin receptor agonist, focused on improving clinical pregnancy and live birth rates in women undergoing in-vitro fertilization (IVF). Geographically, the majority is from Switzerland.

ObsEva (CHIX:OBSNZ) Headlines

No Headlines